Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07661446 · ClinicalTrials.gov registry record · Phase 1
Cannabis and Opioid Use Disorder, Study 2
A Phase 1 study, sponsored by University of Kentucky.
- Not yet
- Registry status
- Phase 1
- Development phase
- 100
- Enrollment target
NCT07661446 is a Phase 1 study that has not yet begun recruiting, run by University of Kentucky. The registered enrollment target is 100 participants.
The verdict
NCT07661446, a Phase 1 study, has not yet begun recruiting, sponsored by University of Kentucky.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 100 participants
- Enrollment target
Study Summary
This inpatient study enrolls healthy individuals who have opioid use disorder. Participants live at the University of Kentucky Hospital for approx. 6 weeks. During this time, we will examine how repeated doses of oral cannabis and acute doses of oral and inhaled cannabis 1) modify the intensity and time course of opioid withdrawal, 2) modify the effects of intranasal opioid administration and 3) impact the safety of opioid administration.
Interventions
- DRUG Inhaled Cannabis
- DRUG Intranasal Opioid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-07-30 |
| Est. Completion | 2030-01-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07661446
The ClinicalTrials.gov registry entry for NCT07661446 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kentucky, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Inhaled Cannabis is the first listed.
NCT07661446 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07661446 about?
NCT07661446 is a clinical study titled "Cannabis and Opioid Use Disorder, Study 2". This inpatient study enrolls healthy individuals who have opioid use disorder. Participants live at the University of Kentucky Hospital for approx. 6 weeks. During this time, we will examine how repeated doses of oral cannabis and acute doses of oral and inhaled cannabis 1) modify the intensity and ...
What is the current status of trial NCT07661446?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 100 participants. The study started on 2026-07-30. Estimated completion is 2030-01-30.
What interventions are being tested in trial NCT07661446?
The interventions under investigation include: Inhaled Cannabis (DRUG), Intranasal Opioid (DRUG).
Who is sponsoring clinical trial NCT07661446?
This trial is sponsored by University of Kentucky, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.